Esperion Therapeutics
ESPR
ESPR
121 hedge funds and large institutions have $392M invested in Esperion Therapeutics in 2015 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 51 increasing their positions, 31 reducing their positions, and 54 closing their positions.
Holders
121
Holders Change
-30
Holders Change %
-19.87%
% of All Funds
3.38%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
25
Increased
51
Reduced
31
Closed
54
Calls
$13.8M
Puts
$12.1M
Net Calls
+$1.7M
Net Calls Change
-$75.6M
Top Buyers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
JG
176
Jefferies Group
New York
| – | – | – | – |
|
|
PA
177
Perceptive Advisors
New York
| – | – | – | – |
|
|
PVI
178
Pura Vida Investments
New York
| – | – | – | – |
|
179
D.E. Shaw & Co
New York
| – | – | – | – |
|
|
PCM
180
Prelude Capital Management
New York
| – | – | – | – |
|
|
SPPAM
181
Summit Partners Public Asset Management
Boston,
Massachusetts
| – | – | – | – |
|